Neuropsychological Intervention for a Seniors Mental Health Population With Mild Cognitive Impairment
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Nova Scotia Health Authority
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Change in everyday memory functioning
Study Overview
Brief Summary
The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Clinical diagnosis of Mild Cognitive Impairment
Exclusion Criteria
- •Clinical diagnosis of dementia
- •History of neurological conditions known to impair cognition
- •History of alcohol or drug abuse
- •History of chronic psychiatric illness
- •Current symptoms of moderate to severe depression (Geriatric Depression Scale >19) or anxiety (Beck Anxiety Inventory >15)
Arms & Interventions
No cognitive training
Cognitive training
Intervention: Cognitive training (Behavioral)
Outcomes
Primary Outcomes
Change in everyday memory functioning
Time Frame: Measured at baseline and months 3, 5, 8
Rivermead Behavioural Memory Test (3rd Edition)
Secondary Outcomes
- Feasibility(Measured at end of study)
- Change in memory perception(Measured at baseline and months 3, 5, 8)
- Change on traditional memory testing(Measured at baseline and months 3, 5, 8)
- Change in quality of life(Measured at baseline and months 3, 5, 8)
- Change in mood (i.e., self-report symptoms of depression)(Measured at baseline and months 3, 5, 8)
- Change in mood (i.e., self-report symptoms of anxiety)(Measured at baseline and months 3, 5, 8)
- Change in other psychiatric symptoms (informant-report)(Measured at baseline and months 3, 5, 8)
- Change in caregiver burden(Measured at baseline and months 3, 5, 8)
